Bank Julius Baer & Co’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-4,024
Closed -$1.07M – 757
2021
Q4
$1.07M Buy
+4,024
New +$1.08M 0.01% 343
2021
Q2
– Sell
-100
Closed -$19K – 864
2021
Q1
$19K Sell
100
-150
-60% -$30.8K ﹤0.01% 751
2020
Q4
$48K Buy
+250
New +$45.5K ﹤0.01% 686
2020
Q2
– Sell
-600
Closed -$58K – 734
2020
Q1
$58K Buy
+600
New +$57.9K ﹤0.01% 536

Other funds holding RGEN

Bank Julius Baer & Co's RGEN Position: Q1 2022 in Review

Bank Julius Baer & Co sold out of Repligen (RGEN) in Q1 2022, closing a stake of 4,024 shares — an estimated $1.07M sold.

Bank Julius Baer & Co first reported a position in RGEN in Q1 2020 and held it in 4 quarters. The position peaked at $1.07M in Q4 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Bank Julius Baer & Co reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Bank Julius Baer & Co sold 4,024 Repligen shares in Q1 2022, an estimated $1.07M.
  • Bank Julius Baer & Co first reported a position in Repligen in Q1 2020 and held it in 4 quarters.
  • Bank Julius Baer & Co's Repligen position peaked at $1.07M in Q4 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Bank Julius Baer & Co's 13F filing for Q1 2022, filed 9 May 2022.